- Short report
- Open Access
Tracking distinct microglia subpopulations with photoconvertible Dendra2 in vivo
Journal of Neuroinflammation volume 18, Article number: 235 (2021)
The ability to track individual immune cells within the central nervous system has revolutionized our understanding of the roles that microglia and monocytes play in synaptic maintenance, plasticity, and neurodegenerative diseases. However, distinguishing between similar subpopulations of mobile immune cells over time during episodes of neuronal death and tissue remodeling has proven to be challenging.
We recombineered a photoconvertible fluorescent protein (Dendra2; D2) downstream of the Cx3cr1 promoter commonly used to drive expression of fluorescent markers in microglia and monocytes. Like the popular Cx3cr1–GFP line (Cx3cr1+/GFP), naïve microglia in Cx3cr1–Dendra2 mice (Cx3cr1+/D2) fluoresce green and can be noninvasively imaged in vivo throughout the CNS. In addition, individual D2-expressing cells can be photoconverted, resulting in red fluorescence, and tracked unambiguously within a field of green non-photoconverted cells for several days in vivo.
Dendra2-expressing retinal microglia were noninvasively photoconverted in both ex vivo and in vivo conditions. Local in vivo D2 photoconversion was sufficiently robust to quantify cell subpopulations by flow cytometry, and the protein was stable enough to survive tissue processing for immunohistochemistry. Simultaneous in vivo fluorescence imaging of Dendra2 and light scattering measurements (Optical Coherence Tomography, OCT) were used to assess responses of individual microglial cells to localized neuronal damage and to identify the infiltration of monocytes from the vasculature in response to large scale neurodegeneration.
The ability to noninvasively and unambiguously track D2-expressing microglia and monocytes in vivo through space and time makes the Cx3cr1–Dendra2 mouse model a powerful new tool for disentangling the roles of distinct immune cell subpopulations in neuroinflammation.
New mouse for tracking microglia and all mononuclear phagocytes both ex and in vivo within the CNS over time.
Dendra2 protein is stable enough to survive tissue processing for immunohistochemistry and flow cytometry quantification.
Simultaneous fluorescence imaging of Dendra2 and light scattering measurements can be used to assess the immune response to retinal damage.
Chronic in vivo imaging reveals mixed populations of microglia and monocytes during retinal degeneration.
Microglia are the long-lived, yolk-sac derived resident immune cells of the central nervous system (CNS) that prune developing circuits, maintain healthy synaptic contacts in adulthood, and phagocytose debris and pathogens [1,2,3]. Recent work suggests the existence of microglial subpopulations, which may have important consequences for their baseline function and their response to disease [4,5,6,7]. In addition, damage or disease can cause the recruitment of bone-marrow derived monocytes across the blood–retinal barrier, and these monocytes can assume morphologies and expression patterns that are similar to the native microglia yet have distinct cellular functions or susceptibilities to subsequent insults [1, 8,9,10,11]. Work in the last 5 years has sought to identify specific molecular markers for subpopulations of microglia, monocytes, and monocyte-derived macrophages, though such markers may be highly dependent on the cells’ activation states and surrounding environments, making their use across models and CNS niches difficult [12, 13].
Dendra2 (D2) is a monomeric, photoconvertible fluorescent protein originally cloned from the soft coral Dendronephthya sp. [14,15,16] with a similar overall structure to that of GFP . Like GFP, the unconverted form of D2 has a peak excitation at 490 nm and a peak emission at 507 nm; however, in D2, short wavelength light induces a structural photoconversion that shifts the spectral properties to longer wavelengths, with a peak excitation of 553 nm and a peak emission of 573 nm [14, 18]. Unlike many other photoswitchable proteins, the conversion from green (gD2) to red (rD2) is permanent, with the red signal only decaying due to protein turnover . Thus, D2 fluorescence acts as a stable, long-lived marker that allows cells to be noninvasively tagged and tracked over space and time.
While D2 has been incorporated into several plant models  and used in cell culture work , its utilization in living animals has been limited. Examples of in vivo applications include neutrophil trafficking during inflammation in zebrafish , quantifying protein turnover rates in vivo in C. elegans , imaging vascular endothelial cell mitochondria in the mouse brain , and tagging leukocytes to track lymph node-homing in mice using fluorescence activated cell sorting (FACS) . The diversity of D2 applications across animal systems underscores the utility of this small, photoconvertible protein for cell identification and discrimination using current fluorescent imaging technology.
To help track individual microglia and monocyte-derived cells over space and time, we developed a mouse line expressing D2 under the Cx3cr1 promoter, the expression of which is commonly used for myeloid lineage tracing both ex vivo and in vivo [25, 26]. In vivo high-resolution retinal imaging of Cx3cr1-driven GFP expression allows individual microglia to be visualized at single cell resolution, but unambiguously following specific microglia over days has not been possible owing to the highly mobile nature of the cells, even in healthy tissue. Here we show that photoconversion of Cx3cr1-driven D2 expression can be used to label specific subpopulations of microglia and monocytes over several days in ex vivo and in vivo retinal imaging applications and flow cytometry assays, allowing us to track and quantify the cellular behavior of these subpopulations across the retina over time.
All animal procedures were performed in accordance with the University of California, Davis and Biocytogen’s Institutional Animal Care and Use Committees and all relevant guidelines and regulations. Cx3cr1–GFP (Cx3cr1GFP/GFP) mice were obtained from Jackson Labs (strain #005582), crossed to C57Bl/6 J mice (Jackson Labs strain #000664), and genotyped to ensure they did not contain either the rd8 or rd1 mutations. Cx3cr1–Dendra2 mice (Cx3cr1D2/D2) were generated as described below. Both strains were housed under 12/12 h diurnal cyclic light, with food and water available ad libitum. Arr1−/− Cx3cr1+/D2 mice were created by crossing Arr1−/− mice [27, 28] with Cx3cr1D2/D2 mice. Mice with the Arrestin-1 background were born and maintained in constant darkness before exposure to uniform white light of 200 lx, which initiated retinal degeneration. Both male and female adult animals were used in these studies.
Generation of the Cx3cr1–Dendra2 mutant mouse
Dendra2 knock-in mice were generated by Biocytogen, Inc. using CRISPR/Cas9 methodology. In brief, to generate the gene targeting vector, single guide RNAs were designed to target two sites of exon 2 of the Cx3cr1 gene. For each targeting site, candidate sgRNAs were designed by the CRISPR design tool (http://crispr.mit.edu), and screened for on-target activity using UCA™ (Universal CRISPR Activity Assay), a sgRNA activity detection system developed by Biocytogen that is simpler and more sensitive than MSDase assay. The Cas9 mRNA and sgRNAs were transcribed by T7 RNA polymerase by PCR amplification, gel purified, and used as the template for in vitro transcription using the MEGAshortscript T7 kit (Life Technologies) according to the kit protocol. The Cas9 mRNA and sgRNAs were purified using the MEGAclear kit and eluted with RNase-free water. To minimize random integrations, a circular donor vector was employed. The gene targeting vector containing Dendra2–SV40-pA and 2 homology arms of left (1500 bp) and right (1500 bp) each was used as a template to repair the DSBs generated by Cas9/sgRNA. The region coding first 130 amino acids was replaced by Dendra2–SV40-pA.
C57BL/6 N female mice and KM mouse strains were used as embryo donors and pseudopregnant foster mothers, respectively. Super-ovulated female C57BL/6 N mice (3–4 weeks) were mated to C57BL/6 N stud males, and fertilized embryos were collected from the ampullae of the dams. Optimized concentrations of Cas9 mRNA, sgRNAs, and donor vector were mixed and co-injected into the cytoplasm of one-cell stage fertilized eggs. After injection, surviving zygotes were transferred into oviducts of KM albino pseudopregnant females.
Genomic DNA extracted from tails of the offspring was digested with AseI or ScaI (NEB), separated on a 1% agarose gel, and transferred to a positively charged nylon membrane (Hybond N + ; Amersham International plc) for Southern Blot analysis. The blot was hybridized overnight using a DIG Easy Hyb Granules (Roche Applied Science Inc.) at 42 °C with a PCR-generated probe homologous to either the external or internal insertion sequences. Both 3’-external and internal DIG-labeled probes were prepared by PCR using Taq DNA polymerase incorporating DIG-11-dUTP (PCR DIG probe synthesis kit; Roche Applied Science Inc.) according to the manufacturer’s instruction. Hybridization signals were then detected using the DIG Luminescent Detection Kit (Roche Applied Science Inc.). The following labeled primers were used to amplify the 3’-external (422 bp) probe: ACCCAGTTGGCCATGTCCCTT (forward primer) and GGCCTGGGTCTTGCCCTGAC (reverse primer). For the internal (530 bp) probe, the following primers were used: CAGACCGCCAACCTGACCGT (forward primer) and ACGGCGTGCTCGTACAGCTT (reverse primer). Mice bearing successful knock-ins were outcrossed to C57Bl/6 J mice (Jackson Labs) for several generations and genotyped to ensure they did not contain either the rd8 or rd1 mutations commonly found in inbred strains.
Mice were sacrificed by carbon dioxide euthanasia and eyes enucleated and submerged in 4% paraformaldehyde at room temperature. After 5 min of fixation, the cornea and lens were removed, and the eyecups were fixed for an additional 20–25 min. Retinas were removed from fixed eyecups and relieving cuts were made for flattening. Retinas were incubated in 1% Triton X-100 in 1X phosphate buffered saline (PBS) overnight at 4 °C, and then blocked with normal serum for 2 h at 37 °C. Retinas were incubated with primary antibodies overnight at 4 °C, washed 3 times in 1X phosphate buffered saline, 0.5% bovine serum albumin, with 0.5% Triton X-100 (PBT) for 15–30 min at room temperature, and incubated in secondary antibody/pre-conjugated primary solution for 1.5–2 h at 37 °C before 3 PBT washes and mounting with ProLong Diamond Antifade with DAPI (Invitrogen). Tissue was stained for GFP (1:300, Rockland) and Iba1 (1:1000, Wako), followed by Alexa Fluor-conjugated secondary antibody (1:300; Invitrogen). Iba1 is a calcium-binding adapter protein used as a standard molecular marker used to identify microglia  and GFP was used to locate Dendra2, which is cross-reactive due to their similar structure . Tissue was imaged using a Nikon A1 confocal microscope.
Ex vivo imaging and photoconversion
Mice were euthanized by carbon dioxide narcosis and the eyes removed. Retinas were excised, cut into a clover-leaf shape for flattening, and placed into glass-bottomed Petri dish filled with Dulbecco's Modified Eagle Medium (DMEM, Sigma Aldrich) supplemented with 10% Fetal Bovine Serum (FBS; Corning) and secured with overlying mesh. The dish was then placed in an imaging chamber (Thermo Scientific) with 10% CO2 and maintained at 37 °C. Retinas were imaged on a Nikon A1 imaging system for up to 5 h. Dendra2 was converted at the lowest 405 nm laser power setting, which corresponded to 3 µW at the imaging stage for 2 min. Converted area sizes ranged from cell soma/branches (~ 20 × 20 µm) to multiple cells (~ 320 × 320 µm). Excitation and conversion lasers were simultaneously used for some spectral imaging experiments to measure the rate of Dendra2 conversion.
Flow cytometry was performed using a protocol modified from an established method [8, 30]. After dissection, each retina was incubated in 1 mL of digestion buffer containing: Hank’s Balanced Salt Solution (10–547F, Lonza), 5% FBS, 10 mM HEPES, 0.7 mg/mL calcium chloride, 1.5 mg/mL Collagenase A (10103586001, Roche), and 0.1 mg/mL DNase I (10104159001, Roche) at 37 °C for 15 min. Following incubation, each retina was gently dissociated, and the resulting single-cell suspension was washed, filtered through a 70 µm cell strainer, centrifuged at 350×g for 5 min, and resuspended in PBS. Cells were stained for viability (Zombie Viability NIR, 423105, Biolegend), and blocked with Fc light chain antibodies (14016186, eBiosciences), supplemented with normal rat serum and normal mouse serum. Cells were then incubated with Brilliant Violet 421 anti-mouse CD45 (103133, Biolegend) and Alexa Fluor 647 anti-mouse/human CD11b (101220, BioLegend). Cell suspensions were washed in PBS containing 0.5% Bovine Serum Albumin (BSA), centrifuged at 350×g for 5 min, and resuspended in 0.5% BSA in PBS with 1:50 EDTA. Bead controls were created using AbC Total Antibody Compensation Bead Kit (A10497, Invitrogen) and ArC Amine Reactive Compensation Bead Kit (A10628, Invitrogen). Data were acquired on a Cytoflex flow cytometer and analyzed with FlowJo software (Tree Star). Each retina was considered a single sample; 200,000 events were analyzed for each sample.
In Vivo imaging and Dendra2 conversion
A custom-built, combined SLO and OCT system was used for fluorescence retinal imaging and Dendra2 conversion equipped with an OBIS LX/LS Laser Box (Coherent Inc. Santa Clara, CA, USA) with 3 laser diode modules . A 488 nm laser diode module (120 µW at the mouse pupil) was used to excite green Dendra2, and a 561 nm laser diode module was used to excite red Dendra2. The 561 nm beam power varied between 130 and 200 µW at the mouse pupil. A 405 nm laser diode module was used to illuminate the retina and convert Dendra2 from green to red. The power of the 405 nm exposure ranged from 20 to 100 µW for 5–10 min, and the converted area ranged from 0.13 mm2 to 1.2 mm2. Consequently, the light fluence varied from 7.5 to 22.5 J/cm2 at the cornea, resulting in 3–9 J/cm2 radiant exposure at the retinal surface when corrected for cornea and lens transmittance .
For imaging, the mice were anesthetized with 2–2.5% isoflurane and positioned on a heating pad at 37 °C. The eyes were dilated and cyclopledged with tropicamide and phenylephrine and corneal hydration was maintained with Hypromellose gel (GenTeal Tears Severe; Alcon). Widefield SLO and OCT images spanned 51° of visual angle (2193 µm), while digitally “zoomed” images ranged between 200 µm for obtaining spectra or 728 µm for imaging the injury and response fields in the light damage model.
A superluminescent diode (860 nm, 132 nm bandwidth; Broadlighter T-860HP; Superlum) was used for OCT imaging (600 µW at pupil) and causing damage (8mW at pupil) as described previously . OCT images were then processed and flattened for display [33, 34]. En face OCT images were taken from the outer nuclear layer, while B-scans were taken from the same location for each timepoint in both models. For the near infrared (NIR) light damage model, B-scans were taken through the center of the injury field.
Spectral imaging was performed with an OceanOptics Spectrometer (QE65000 OceanOptics Inc. Dunedin, FL, USA) over a small field of view (i.e., hyperspectral images were not created as they were in ex vivo spectra). The 488 nm and 561 nm excitation sources were used separately with set of a dichroic mirrors Di01–R488/561 (Semrock, Rochester, NY), with a 503 LP emission filter for the 488 nm excitation and a 561 nm LP emission filter for the 561 nm excitation (Semrock, Rochester, NY). Conversion could not occur during spectral imaging, because different fibers were required for 405 vs 488/561 nm source delivery. For each data set, 20 spectra with 1000 ms integration time were obtained and averaged.
Fluorescence image analysis
Images from both ex vivo and in vivo experiments were analyzed with ImageJ (FIJI; NIH; ) and Python (SciPy stack and Sci-Kit Image; ). Ex vivo images taken on the Nikon A1 microscope were exported to tiff format using NIS elements viewer (Nikon Instruments, Inc.). For in vivo images, backgrounds were adjusted to provide similar overall contrast. To measure the SLO fluorescence signal in the injury and response field, an ROI 728 × 728 µm, centered on the center of the injury field in the widefield images, was created. The background was determined using the Rolling Ball background subtraction function was created using a radius of 50px and averaged to produce the background value. The pixel intensity was then averaged in the ROI and divided by the background value to produce the signal strength. This normalization served to account for differences in excitation laser power or other issues that created changes in raw signal intensity.
Spectral image analysis
Spectral images were analyzed with ImageJ and Python. For hyperspectral ex vivo image and movie display, the NIS elements viewer was used to select the channels with the peak gD2 and rD2 fluorescence, then exported to tiffs and appropriate Look-Up Tables (LUTs) were applied. For analysis, the full hyperspectral image was exported as tiff and analyzed with custom-written Python code. For time series of D2 conversion, the spectra in 10 nm width bins are display for each scan. Spectra were color-coded from green to red based on scan number and each scan took ~ 1 s. Twenty scans were taken prior to 405 nm exposure and were not displayed. To determine the time course of gD2 loss and rD2 gain, the 10 nm-wide bins that included the peak gD2 and rD2 emission wavelengths were taken and displayed, including the 20 pre-405 nm exposure scans.
To quantify converted rD2, spectral data were unmixed using the theoretical rD2 and autofluorescence spectra. The theoretical spectrum was obtained from the Evrogen website https://evrogen.comand was corrected with the spectrum of the 561 nm LP filter from Semrock (see Methods section "In vivo imaging and Dendra2 conversion"). The autofluorescence spectrum was from an unconverted Dendra2 mouse with 561 nm excitation. Non-negative least squares regression was used in the linear unmixing algorithm to obtain the intensity of the rD2 fluorescence spectrum and the relevant autofluorescence spectrum. To quantify the amount of rD2 over time, the rD2 intensity was normalized to the autofluorescence intensity to control for variations in laser intensity and optical alignment of the mouse eye.
Dendra2-expressing retinal microglia can be efficiently photoconverted in vivo
Cx3cr1D2/D2 mice were generated using CRIPSR/Cas9 to knock-in the Dendra2 (D2) coding sequence behind the Cx3cr1 promoter at the same location previously used to generate Cx3cr1GFP/GFP mice . Immunohistochemical staining of fixed retinas of Cx3cr1D2/D2 mice showed that D2 was expressed in all Iba1+ retinal cells, the vast majority of which are microglia (Fig. 1A). These microglia appeared at normal density with ramified morphologies, suggesting the expression of the exogenous protein had no ill effect on microglia viability or immune activation status. No other retinal cells showed expression of D2.
In live retinal explants of Cx3cr1D2/D2 mice, naïve microglia fluoresced green and had a red–orange color immediately after photoconversion with 405 nm light (Fig. 1B, C, Additional file 1: Movie S1). Spectral analysis of the emitted light allowed quantitative measurement of unconverted green Dendra2 (gD2) and photoconverted red Dendra2 (rD2) over time. Prior to photoconversion, the combined emission spectrum from 488 and 560 nm excitation showed a strong primary peak at 505 nm corresponding to gD2 and a small secondary peak at 571 nm corresponding to rD2 (Fig. 1D, green trace at time 0 s). During the 488 nm scanning, the 505 nm signal noticeably decreased, while the red 571 nm signal did not change, consistent with photobleaching of gD2 that did not cause photoconversion to rD2 (Fig. 1E, green trace before 405 nm onset). Following 405 nm laser exposure for 2 min (19 µW; 2175 J/cm2 radiant exposure), the primary green peak decreased, and the secondary red peak increased, reflecting rapid photoconversion from gD2 to rD2 (Fig. 1D; yellow, orange, and red traces). Interestingly, the rate of increase of rD2 fluorescence was much greater than the rate of decrease of gD2 fluorescence (Fig. 1E, compare orange and green traces), as has also been noted by other groups [14, 17, 37, 38]. The complete conversion of all D2 protein within a cell never occurred such that some gD2 protein was still detectible after 405 nm excitation in all experiments.
We next imaged the retinas of Cx3cr1D2/D2 mice in vivo with combined Scanning Laser Ophthalmoscopy (SLO) to visualize the fluorescent cells and Optical Coherence Tomography (OCT) with three-dimensional light scattering to visualize the retinal architecture. Similar to ex vivo live observations, in vivo SLO imaging with 488 nm excitation revealed a retinal microglial population that appeared qualitatively normal in density and distribution, with no obvious rD2 fluorescence (Fig. 2A, unconverted). After 405 nm exposure, there was a large increase in rD2 fluorescence and a concomitant decrease in gD2 fluorescence in the converted area (Fig. 2A, converted). Photoconverted cells could be tracked in vivo over multiple days, with rD2 fluorescence gradually decreasing over the course of a week (Fig. 2B). Spectroscopy was used to quantify in vivo changes accurately and objectively in a subset of cells across a small area (219 × 219 µm) over time (Fig. 2C). The disappearance of red fluorescence is expected based upon the gradual protein turnover of the rD2 protein, leaving only newly translated gD2 within existing cells; however, at the current resolution of our in vivo imaging, it was not possible to differentiate between loss of the rD2 protein and disappearance of red fluorescent cells themselves.
Of note, a high fluence of 405 nm light (9 J/cm2) increased OCT light scattering in the scanned area in 3 out of 4 retinas imaged, denoting light-induced retinal damage; however, lower fluences of 405 nm light (4.5–7 J/cm2) did not cause any detectable retinal damage, while still permitting sufficient photoconversion to readily tag individual microglia with our imaging system. In some retinas, low fluences of 405 light (4.5–7 J/cm2; 5 min duration) that resulted in photoconversion also resulted in recruitment of microglia to the converted area. This was surprising, since there were no corresponding changes in OCT light scattering that are commonly associated with local retinal damage. In all cases, any recruited microglia returned to their normal mosaic spatial distribution within a week.
To quantify the photoconverted and non-converted microglial populations in vivo, we used fluorescence activated cell sorting (FACS). Since Cx3cr1 has been shown to have immunomodulatory and neuroprotective effects in the retina [12, 39, 40], for this and all subsequent experiments, heterozygous mice (e.g., Cx3cr1+/D2) were used to ensure microglia possessed a functional copy of Cx3cr1 and a single copy of the D2 label. We converted four large areas in one eye of a Cx3cr1+/D2 mouse, creating a large subpopulation of rD2 microglia across the retina (Fig. 3A). Within 24 h after conversion, mice were euthanized and the retinas removed; Cx3cr1+/GFP retinas were processed in parallel for comparison. Retinas were dissociated and all live, single cells expressing CD45+ Cd11b+ with high Cx3cr1 expression (as measured by GFP fluorescence) were quantified with flow cytometry, using the gating shown in Fig. 3B. As expected, the Cx3cr1+/GFP mouse retina contained GFP-expressing cells but no red fluorescence (Fig. 3C, left). The unconverted control eye of the Cx3cr1+/D2 mouse was similar, with only a few rD2 cells detected (Fig. 3C, middle). However, the converted eye in the Cx3cr1+/D2 mouse showed fewer gD2 microglia and a greatly increased number of rD2 microglia (Fig. 3C, right). Interestingly, the green fluorescence was noticeably brighter in the Cx3cr1+/D2 mice compared to the Cx3cr1+/GFP mice (Fig. 3C). These results demonstrate that expression from a single copy of D2 and its photoconversion in vivo are sufficient to be used for flow cytometry and cell sorting.
Photoconverted Dendra2 to identify resident microglia during widespread retinal degeneration
Having shown that flow cytometry could be performed immediately after in vivo photoconversion, we next used FACS to quantify photoconverted cells over time in a model of neurodegeneration. Mice lacking Arrestin-1 (Arr1, also known as visual arrestin) were used to noninvasively induce photoreceptor degeneration. Arr1 is a photoreceptor-specific cytosolic protein that deactivates photoexcited rhodopsin, shutting down the rod phototransduction cascade [27, 41]. In Arr1−/− mice, rods become extraordinarily sensitive to light but continue to be healthy as long as the animals are dark-reared; prolonged exposure to room light induces photoreceptor degeneration [28, 42,43,44], resulting in the loss of half of the photoreceptors within 48 h . Arr1−/− Cx3cr1+/D2 mice were dark-reared and their microglia photoconverted in four large areas in one eye of each mouse, either prior to (“Healthy Retina”, Fig. 4A) or after 4 days of light-induced photoreceptor degeneration (“Degenerating Retina”, Fig. 4B–D). Quantification of gD2 and rD2 cells in the retina by FACS revealed that the population of photoconverted rD2 microglia was remarkably stable regardless of the health status of the retina for up to 48 h (Fig. 4A–C). As before, the unconverted control eyes showed negligible rD2 cells (Fig. 4D). Together, these data demonstrate that subpopulations of retinal microglia can be reliably quantified in a degenerating retina for at least 48 h after photoconversion, and that there is no detectable microglial cell loss during this time of profound photoreceptor clearance.
Next, we used this degeneration model to monitor cell subpopulations during retinal degeneration in vivo using SLO retinal imaging. In healthy mice (prior to inducing degeneration), we photoconverted resident microglia across the full area of the visible retina using the 405 nm laser (Fig. 4E). Both control (Arr1+/+ Cx3cr1+/D2) and experimental mice (Arr1−/− Cx3cr1+/D2) were then exposed to continuous room light, initiating retinal degeneration in the Arr1−/− mouse. Within 24 h, green cells that had not been photoconverted were visible within and near retinal vessels only in the degenerating retinas (Fig. 4F, white arrows). In contrast, retinas of WT mice 24 h after conversion contained only a population of yellow/orange cells and no green cells (Fig. 4G). Since resident microglia contained both gD2 and rD2, giving them a yellow/orange appearance in the composite image, the bright green cells that were easily distinguishable from the rD2-containing population in the degenerating Arr1−/− retinas likely originated from outside the retinal field of view, presumably having extravasated from the retinal vasculature as previously described .
Microglia with converted Dendra2 can be tracked during a response to localized photoreceptor damage
One of the great promises of this mouse line is the ability to track individual microglia over space and time in vivo. Thus, we used local laser damage in the retinas of Cx3cr1+/D2 mice to study how cells move to and from a local site of injury as the damaged cells are removed and the tissue reorganizes. Microglia were first photoconverted in a small retinal region (Fig. 5A, conversion site) without causing damage (Fig. 5E, pre-damage OCT). Subsequently, photoreceptors within the rD2 field were damaged using a high intensity near-infrared (NIR) laser (Fig. 5A, injury site), causing an immediate increase in OCT light scattering indicative of tissue damage (Fig. 5E) that could be monitored over time (Fig. 5F).
After NIR damage, all rD2-labeled microglia migrated to the injury field and progressively formed a dense, bright cluster of cells over 3 days (Fig. 5A, zoom 5D). Initially the rD2 cells accumulated on the side of the injury field closest to the region from which they had migrated. Over a period of days, the rD2 cells became dispersed throughout the injury field. After 1 week, the structural damage visible by OCT was less distinct and most of the microglia had left the injury locus; only a small cluster of fluorescent cells occupied the core damaged region (Fig. 5A, zooms 5C, D). By this time, the rD2 label had become difficult to detect, with only a few faint flocculent red-fluorescent bodies visible (Fig. 5D, 1 week timepoint). Finally, at 2 and 3 weeks after NIR damage, no rD2 label was at all detectable and the green microglia distribution had largely returned to normal, with only a small cluster of gD2 cells remaining in the core of the injury field (Fig. 5A, zooms 5C, D).
To track the microglial response and the change in rD2 fluorescence over time, we quantified the intensity of gD2 and rD2 fluorescence from the SLO images, following an established protocol . The SLO gD2 signal was initially prominent but lost nearly twofold intensity after 405 nm conversion (Fig. 5B, 488 nm Ex). This gD2 signal subsequently increased over time, peaking at 72 h presumably due to the accumulation of cells at the injury locus. From 1 to 3 week post-damage, the gD2 signal decreased, returning nearly to baseline by 3 weeks. Image analysis of the emitted light showed an immediate loss of gD2 and gain of rD2 signal after 405 nm exposure, consistent with photoconversion (Fig. 5B, 561 nm Ex). After 24 h, the rD2 signal began to gradually fall, presumably as protein levels in the cell turned over, reaching baseline around 7 days (Fig. 5B). Overall, these results show that distinct microglial populations can be reliably tracked over space and time as they respond to neuronal injury and degeneration.
Here we show that the Cx3cr1–Dendra2 mouse (Cx3cr1+/D2) is a useful model for labeling resident microglia and unambiguously tracking immune subpopulations for several days during neuronal injury and tissue remodeling.
In the Cx3cr1D2/D2 homozygous mouse, the endogenous Cx3cr1 alleles have been replaced by knock-ins of the fluorescent protein Dendra2, the same strategy employed in the commonly used Cx3cr1GFP/GFP mouse [25, Jackson Labs strain 005582]. Healthy neurons express the receptor’s ligand, Cx3CL1, which helps maintain microglia in a normal basal state, and studies indicate that mice heterozygous for Cx3cr1+/GFP have microglia that function normally in the retina [40, 45, 46]. For our study, we likewise used heterozygous Cx3cr1+/D2 mice and did not observe any qualitative abnormalities in microglia form or function. Histology and in vivo SLO imaging of retinal microglia showed a ramified morphology and spatial distribution that is typical for cells in healthy CNS retina. Following photoreceptor damage, these microglia underwent a morphological change and migrated to the affected photoreceptors, a functional response indistinguishable from observations in wild-type (C57BL/6 J) and Cx3cr1+/GFP mice [1, reviewed in 12, 47]. Together, these data indicate that microglia in the Cx3cr1+/D2 mouse retain their ability to respond to neurodegeneration and function comparably to those in the Cx3cr1–GFP mouse.
While naïve Cx3cr1+/D2 cells continually produce green GFP-like fluorescence, photoconversion in cells of interest can be efficiently driven by noninvasive 405 nm light exposure, converting selected cells to a permanent RFP-like fluorescence that lasts up to a week (Figs. 1, 2, 5). Once photoconverted, rD2 can be tracked both ex vivo and in vivo in healthy and degenerating retinas, and the D2 protein is stable enough to survive tissue processing for flow cytometry (Figs. 3, 4). In principle, the Cx3cr1+/D2 mouse should also be useful for studying rates of protein turnover, though we did not use it for this purpose. In our in vivo studies that imaged the same cell populations across several days, cell crowding and intermixing did not allow quantitative interpretation of the rD2 and gD2 ratio to estimate protein turnover rates. Overall, the ability to track, sort, and quantify naïve gD2 and photoconverted rD2 microglia simultaneously is a powerful tool for disentangling the roles of mixed immune cell populations.
A variety of other tools have been developed to fluorescently label resident microglia and infiltrating macrophages and visualize their dynamics during health and disease [25, 48,49,50,51,52,53]; however, very few of these are able to target and track spatially distinct subsets of microglia that are known to exist [4,5,6,7]. One exception is the Cx3cr1–CreER mouse that has been used to develop the “Microfetti” mouse in which individual long-lived macrophages are labeled with one of four fluorophores . This mouse allows subsets of microglia to be distinctly labeled and has been useful for better understanding microglia proliferation at rest and during activation. However, in this line the fluorophore expression after tamoxifen administration is random, and thus spatially distinct subsets of microglia cannot be purposefully targeted. In contrast, the Cx3cr1+/D2 mouse described here allows individual, spatially distinct subsets of microglia, at varying scales, to be specifically tagged and followed over time using a variety of in vivo, ex vivo, and histological techniques.
In this study, we utilized the Cx3cr1–Dendra2 mouse to noninvasively tag and track subpopulations of cells in the retina. Specifically, in response to widespread degeneration, photoconverted rD2 resident microglia were joined by naïve gD2 circulating Dendra2-expressing cells that exited the retinal vasculature and infiltrated the parenchyma (Fig. 4E, white arrows). Furthermore, following local laser damage, a subpopulation of photoconverted microglia clustered at the injury locus (Fig. 5, rD2 at 1–3 days) then redistributed as the tissue recovered (Fig. 5B, 1–3 weeks). This ability to specifically label subsets of cells could also permit functional comparisons between distinct populations of macrophages using a variety of downstream techniques that typically do not include spatial information, such as single-cell RNAseq and ATAC-seq. Thus, this mouse can be used both to track distinct macrophages over time in the tissue and to probe specific roles of unique immune populations during injury and degeneration.
Distinguishing between subpopulations of microglia and other immune cells within the CNS during episodes of neuronal death and tissue remodeling has proven to be challenging. Here we describe the novel Cx3cr1–Dendra2 mouse (Cx3cr1+/D2) in which subpopulations of microglia can be photoconverted from green to red and tracked unambiguously for several days during neuronal injury and tissue remodeling. Naïve and photoconverted Dendra2 signal can also be used for flow cytometry and cell sorting of distinct microglia populations. This mouse line has additional uses beyond retinal microglia studies, such as tracking resident immune cells in other CNS compartments, quantifying protein turnover within microglia, and studying the function of Cx3cr1-expressing myeloid cells outside the CNS.
Availability of data and materials
The data sets created during the current study are available from the corresponding author on reasonable request.
Central nervous system
Dulbecco's modified eagle medium
Fluorescence activated cell sorting
Fetal bovine serum
Ganglion cell layer
Green fluorescent Dendra2 protein
Green fluorescent protein
Inner nuclear layer
Optical coherence tomography
Phosphate buffered saline
Phosphate buffered saline, bovine serum albumin, and triton x-100
Red fluorescent Dendra2 protein
Red fluorescent protein
Region of interest
Retinal pigment epithelium
Scanning laser ophthalmoscopy
Yu C, Roubeix C, Sennlaub F, Saban DR. Microglia versus Monocytes: distinct roles in degenerative diseases of the retina. Trends Neurosci. 2020;43:433–49.
Wolf SA, Boddeke HW, Kettenmann H. Microglia in physiology and disease. Annu Rev Physiol. 2017;79:619–43.
Silverman SM, Wong WT. Microglia in the retina: roles in development, maturity, and disease. Annu Rev Vis Sci. 2018;4:45–77.
Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, Walker AJ, Gergits F, Segel M, Nemesh J, et al. Single-Cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50:253-271.e256.
Ronning KE, Karlen SJ, Miller EB, Burns ME. Molecular profiling of resident and infiltrating mononuclear phagocytes during rapid adult retinal degeneration using single-cell RNA sequencing. Sci Rep. 2019;9:4858.
O’Koren EG, Yu C, Klingeborn M, Wong AYW, Prigge CL, Mathew R, Kalnitsky J, Msallam RA, Silvin A, Kay JN, et al. Microglial function is distinct in different anatomical locations during retinal homeostasis and degeneration. Immunity. 2019;50:723-737.e727.
Wieghofer P, Hagemeyer N, Sankowski R, Schlecht A, Staszewski O, Amann L, Gruber M, Koch J, Hausmann A, Zhang P, et al. Mapping the origin and fate of myeloid cells in distinct compartments of the eye by single-cell profiling. EMBO J. 2021;40:e105123.
Karlen SJ, Miller EB, Wang X, Levine ES, Zawadzki RJ, Burns ME. Monocyte infiltration rather than microglia proliferation dominates the early immune response to rapid photoreceptor degeneration. J Neuroinflammation. 2018;15:344.
Sennlaub F, Auvynet C, Calippe B, Lavalette S, Poupel L, Hu SJ, Dominguez E, Camelo S, Levy O, Guyon E, et al. CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol Med. 2013;5:1775–93.
Zhang Y, Wong WT. Innate immunity in age-related macular degeneration. Adv Exp Med Biol. 2021;1256:121–41.
Fletcher EL. Contribution of microglia and monocytes to the development and progression of age related macular degeneration. Ophthalmic Physiol Opt. 2020;40:128–39.
Rashid K, Akhtar-Schaefer I, Langmann T. Microglia in retinal degeneration. Front Immunol. 2019;10:1975.
Eme-Scolan E, Dando SJ. Tools and approaches for studying microglia in vivo. Front Immunol. 2020;11:583647.
Gurskaya NG, Verkhusha VV, Shcheglov AS, Staroverov DB, Chepurnykh TV, Fradkov AF, Lukyanov S, Lukyanov KA. Engineering of a monomeric green-to-red photoactivatable fluorescent protein induced by blue light. Nat Biotechnol. 2006;24:461–5.
Labas YA, Gurskaya NG, Yanushevich YG, Fradkov AF, Lukyanov KA, Lukyanov SA, Matz MV. Diversity and evolution of the green fluorescent protein family. Proc Natl Acad Sci U S A. 2002;99:4256–61.
Chudakov DM, Lukyanov S, Lukyanov KA. Tracking intracellular protein movements using photoswitchable fluorescent proteins PS-CFP2 and Dendra2. Nat Protoc. 2007;2:2024–32.
Adam V, Nienhaus K, Bourgeois D, Nienhaus GU. Structural basis of enhanced photoconversion yield in green fluorescent protein-like protein Dendra2. Biochemistry. 2009;48:4905–15.
Chudakov DM, Lukyanov S, Lukyanov KA. Using photoactivatable fluorescent protein Dendra2 to track protein movement. Biotechniques. 2007;42:553–63.
Griffiths N, Jaipargas EA, Wozny MR, Barton KA, Mathur N, Delfosse K, Mathur J. Photo-convertible fluorescent proteins as tools for fresh insights on subcellular interactions in plants. J Microsc. 2016;263:148–57.
Hasle N, Cooke A, Srivatsan S, Huang H, Stephany JJ, Krieger Z, Jackson D, Tang W, Pendyala S, Monnat RJ Jr, et al. High-throughput, microscope-based sorting to dissect cellular heterogeneity. Mol Syst Biol. 2020;16:e9442.
Yoo SK, Huttenlocher A. Spatiotemporal photolabeling of neutrophil trafficking during inflammation in live zebrafish. J Leukoc Biol. 2011;89:661–7.
Pigazzini ML, Kirstein J. In vivo quantification of protein turnover in aging C. Elegans using photoconvertible Dendra2. J Vis Exp. 2020. https://doi.org/10.3791/61196.
Rutkai I, Evans WR, Bess N, Salter-Cid T, Cikic S, Chandra PK, Katakam PVG, Mostany R, Busija DW. Chronic imaging of mitochondria in the murine cerebral vasculature using in vivo two-photon microscopy. Am J Physiol Heart Circ Physiol. 2020;318:H1379–86.
Martens R, Permanyer M, Werth K, Yu K, Braun A, Halle O, Halle S, Patzer GE, Bosnjak B, Kiefer F, et al. Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance. Nat Commun. 2020;11:1114.
Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol. 2000;20:4106–14.
Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38:79–91.
Xu J, Dodd RL, Makino CL, Simon MI, Baylor DA, Chen J. Prolonged photoresponses in transgenic mouse rods lacking arrestin. Nature. 1997;389:505–9.
Chen J, Simon MI, Matthes MT, Yasumura D, LaVail MM. Increased susceptibility to light damage in an arrestin knockout mouse model of Oguchi disease (stationary night blindness). Invest Ophthalmol Vis Sci. 1999;40:2978–82.
Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57:1–9.
O’Koren EG, Mathew R, Saban DR. Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina. Sci Rep. 2016;6:20636.
Zhang P, Zam A, Jian Y, Wang X, Li Y, Lam KS, Burns ME, Sarunic MV, Pugh EN Jr, Zawadzki RJ. In vivo wide-field multispectral scanning laser ophthalmoscopy-optical coherence tomography mouse retinal imager: longitudinal imaging of ganglion cells, microglia, and Muller glia, and mapping of the mouse retinal and choroidal vasculature. J Biomed Opt. 2015;20:126005.
Henriksson JT, Bergmanson JP, Walsh JE. Ultraviolet radiation transmittance of the mouse eye and its individual media components. Exp Eye Res. 2010;90:382–7.
Miller EB, Zhang P, Ching K, Pugh EN Jr, Burns ME. In vivo imaging reveals transient microglia recruitment and functional recovery of photoreceptor signaling after injury. Proc Natl Acad Sci U S A. 2019;116:16603–12.
Wojtkowski M, Srinivasan V, Ko T, Fujimoto J, Kowalczyk A, Duker J. Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Opt Express. 2004;12:2404–22.
Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–5.
Van Rossum GAD, Fred L. Python 3 reference manual. Scotts Valley: CreateSpace; 2009.
Pakhomov AA, Martynov VI, Orsa AN, Bondarenko AA, Chertkova RV, Lukyanov KA, Petrenko AG, Deyev IE. Fluorescent protein Dendra2 as a ratiometric genetically encoded pH-sensor. Biochem Biophys Res Commun. 2017;493:1518–21.
Makarov NS, Cirloganu C, Perry JW, Lukyanov KA, Solntsev KM. Steady-state and time-resolved spectroscopic studies of green-to-red photoconversion of fluorescent protein Dendra2. J Photochem Photobiol A Chem. 2014;280:5–13.
Zabel MK, Zhao L, Zhang Y, Gonzalez SR, Ma W, Wang X, Fariss RN, Wong WT. Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa. Glia. 2016;64:1479–91.
Wolf Y, Yona S, Kim KW, Jung S. Microglia, seen from the CX3CR1 angle. Front Cell Neurosci. 2013;7:26.
Wilden U, Kuhn H. Light-dependent phosphorylation of rhodopsin: number of phosphorylation sites. Biochemistry. 1982;21:3014–22.
Hao W, Wenzel A, Obin MS, Chen CK, Brill E, Krasnoperova NV, Eversole-Cire P, Kleyner Y, Taylor A, Simon MI, et al. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet. 2002;32:254–60.
Wang T, Chen J. Induction of the unfolded protein response by constitutive G-protein signaling in rod photoreceptor cells. J Biol Chem. 2014;289:29310–21.
Levine ES, Zam A, Zhang P, Pechko A, Wang X, FitzGerald P, Pugh EN Jr, Zawadzki RJ, Burns ME. Rapid light-induced activation of retinal microglia in mice lacking Arrestin-1. Vision Res. 2014;102:71–9.
Beli E, Dominguez JM 2nd, Hu P, Thinschmidt JS, Caballero S, Li Calzi S, Luo D, Shanmugam S, Salazar TE, Duan Y, et al. CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes. J Mol Med (Berl). 2016;94:1255–65.
Paolicelli RC, Bisht K, Tremblay ME. Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front Cell Neurosci. 2014;8:129.
Karlen SJ, Miller EB, Burns ME. Microglia Activation and Inflammation During the Death of Mammalian Photoreceptors. Annu Rev Vis Sci. 2020;6:149–69.
Reyes NJ, Mathew R, Saban DR. Fate Mapping In Vivo to Distinguish Bona Fide Microglia Versus Recruited Monocyte-Derived Macrophages in Retinal Disease. Methods Mol Biol. 2019;1834:153–64.
Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, Mulinyawe SB, Bohlen CJ, Adil A, Tucker A, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016;113:E1738-1746.
Luckoff A, Scholz R, Sennlaub F, Xu H, Langmann T. Comprehensive analysis of mouse retinal mononuclear phagocytes. Nat Protoc. 2017;12:1136–50.
Goldmann T, Wieghofer P, Muller PF, Wolf Y, Varol D, Yona S, Brendecke SM, Kierdorf K, Staszewski O, Datta M, et al. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci. 2013;16:1618–26.
Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, Hempstead BL, Littman DR, Gan WB. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155:1596–609.
McKinsey GL, Lizama CO, Keown-Lang AE, Niu A, Santander N, Larpthaveesarp A, Chee E, Gonzalez FF, Arnold TD. A new genetic strategy for targeting microglia in development and disease. Elife. 2020;9:e54590.
Tay TL, Mai D, Dautzenberg J, Fernandez-Klett F, Lin G, Datta M, Drougard A, Stempfl T, Ardura-Fabregat A, et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat Neurosci. 2017;20:793–803.
We would like to acknowledge Sonia Frick for immunohistochemistry shown in Fig. 1 and Drs. Pengfei Zhang and Robert Zawadzki of the UC Davis Eye Pod Laboratory for assistance setting up the in vivo Dendra2 imaging.
This work was supported by the National Eye Institute (R01-EY24320), the NEI UC Davis Core grant (P30-EY012576), National Institutes of Health Training Grants (T32-EY105387), and the UC Davis Flow Cytometry Core (NIH S10OD018223).
Ethics approval and consent to participate
All animal procedures were performed in accordance with the University of California, Davis and Biocytogen’s Institutional Animal Care and Use Committees and all relevant guidelines and regulations.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Miller, E.B., Karlen, S.J., Ronning, K.E. et al. Tracking distinct microglia subpopulations with photoconvertible Dendra2 in vivo. J Neuroinflammation 18, 235 (2021). https://doi.org/10.1186/s12974-021-02285-x
- Fluorescent protein